Bioventus - Class A opened higher at $11.06, compared with its previous close of $10.99. In the last trading session, the stock traded between $10.82 and $11.19. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Bioventus - Class A is now worth
$ 66.74
Resulting in a loss of
$ 33.26 (33.26%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.12 (-1.07%)
Day High
$11.19
Day Low
$10.82
Day Open
$11.06
Prev Close
$10.99
Volume
4,17,525
1W Return
-4.82%
1M Return
-19.77%
3M Return
-21.50%
6M Return
6.69%
1Y Return
41.19%
Fundamentals
Market Cap ($ Mn)
744
PE Ratio
17.75
PB Ratio
4.14
PEG Ratio
8.10
ROE
16.89%
ROCE
9.97%
EPS (TTM)
$0.09
Investment Returns
1 Week
-4.82%
1 Month
-19.77%
3 Months
-21.50%
6 Months
6.69%
9 Months
34.55%
Financials
Quarterly
All values in $ Mn
147.7
Jun 25
138.7
Sep 25
157.9
Dec 25
132.1
Mar 26
153.2
Jun 26
142.4
Sep 26
Updates
3Nov
Bioventus Q3FY26 Results: Revenue up 3% to $142.4M; guidance trimmed
Bioventus lowered FY26 net sales guidance to $590M-$595M from $600M-$610M, missing the $604.782M analyst estimate. Q3 revenue rose 3% to $142.4 million, while adjusted EBITDA increased 7% to $28.4 million. Adjusted EPS guidance for FY26 was maintained at $0.75-$0.79, consistent with the $0.78 analyst forecast.
10 days ago
3Jul
Halper Sadeh investigates Bioventus Inc. for fiduciary breaches
Halper Sadeh LLC is investigating potential fiduciary duty breaches by Bioventus Inc. officers and directors. Shareholders may seek governance reforms, return of funds, or financial incentives. The firm urges immediate contact due to limited time to enforce rights.
